Nuo Therapeutics AURX
OTC AURX
$1.06 -0.07 (-6.19%)
As of: Nov 19, 2026 · 9:37 AM EST

Nuo Therapeutics (AURX) Receivables (2009 - 2026)

Updated

Nuo Therapeutics' Receivables came in at $1.41 million for Q3 2026, up 116.2% from $652,252 a year earlier and up 20.8% from the prior quarter.

Analysis

Nuo Therapeutics (AURX) Receivables (2009 - 2026) Analysis & Trends

At the end of FY2025, Nuo Therapeutics' Receivables was $561,667, up 126.3% from FY2024.

  • Receivables carries a three-year compound annual growth rate of 82.6% (FY2022 to FY2025).
  • Going back by year, Receivables was $248,205 in FY2024 (-1.0%), $250,703 in FY2023 (+171.6%) and $92,320 in FY2022.
  • The Q3 2026 figure represents the highest quarterly Receivables since Q1 2016.
  • Year-over-year, Receivables has increased for seven consecutive quarters, with growth averaging 105.7% over the last eight quarters.
  • The fastest year-over-year change in Receivables over five years came in Q3 2023 (growth of 666.0%), and the weakest in Q4 2024 (a decline of 1.0%).
  • Business Quant data shows AURX's Receivables at $1.17 million (Q2 2026), $873,669 (Q1 2026) and $561,667 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn 11.32 Bn
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn 9.03 Bn
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn 4.13 Bn
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn 1.72 Bn
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn 6.36 Bn
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn 3.69 Bn
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn 3.11 Bn
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn 937.80 Mn
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 1.48 Bn
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn 1.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.41 Mn
Jun 30, 2026 1.17 Mn
Mar 31, 2026 873,669.00
Dec 31, 2025 561,667.00
Sep 30, 2025 652,252.00
Jun 30, 2025 320,440.00
Mar 31, 2025 276,532.00
Dec 31, 2024 248,205.00
Sep 30, 2024 329,211.00
Jun 30, 2024 304,971.00
Mar 31, 2024 229,769.00
Dec 31, 2023 250,703.00
Sep 30, 2023 232,879.00
Jun 30, 2023 201,497.00
Mar 31, 2023 134,115.00
Dec 31, 2022 92,320.00
Sep 30, 2022 30,400.00
Mar 31, 2022 64,000.00
Jun 30, 2019 9,996.00
Mar 31, 2019 46,959.00
API Access

Nuo Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=AURX&period=max&api_key=YOUR_API_KEY